RTNS 2012
Recent articles
Better tools needed to assess clinical trials
The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.

Better tools needed to assess clinical trials
The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.
Trials and tribulations
Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.

Trials and tribulations
Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.
Compensatory mechanisms
Identifying genetic and other factors that protect children at risk of autism from developing the disorder could provide new avenues for treatment.

Compensatory mechanisms
Identifying genetic and other factors that protect children at risk of autism from developing the disorder could provide new avenues for treatment.
Debate over quality of adult-derived stem cells rages on
As the use of induced pluripotent stem cells grows, researchers are searching for ways to make them behave more predictably.

Debate over quality of adult-derived stem cells rages on
As the use of induced pluripotent stem cells grows, researchers are searching for ways to make them behave more predictably.
Complex case
Multiple levels of complexity make it challenging to develop drugs to treat autism.

Complex case
Multiple levels of complexity make it challenging to develop drugs to treat autism.
Fast-forward
In the last three years, autism researchers have gone from sequencing single genes to whole exomes, as highlighted at the Translational Neuroscience Symposium in Switzerland last week.

Fast-forward
In the last three years, autism researchers have gone from sequencing single genes to whole exomes, as highlighted at the Translational Neuroscience Symposium in Switzerland last week.
Explore more from The Transmitter
‘A gut punch:’ How U.S. neuroscience trainees are grappling with diversity-based funding flux
Ten trainees spoke with The Transmitter about how the precarious state of U.S. federal funding is affecting their research and career plans.

‘A gut punch:’ How U.S. neuroscience trainees are grappling with diversity-based funding flux
Ten trainees spoke with The Transmitter about how the precarious state of U.S. federal funding is affecting their research and career plans.
‘Bioethics and Brains: A Disciplined and Principled Neuroethics,’ an excerpt
In their new book, published earlier this week, Giordano and Shook examine how ethics can guide neuroscience research and its real-world applications.

‘Bioethics and Brains: A Disciplined and Principled Neuroethics,’ an excerpt
In their new book, published earlier this week, Giordano and Shook examine how ethics can guide neuroscience research and its real-world applications.
AI tool estimates social ability by analyzing speech
The system’s code and training data—drawn from one of the largest databases of speech recordings from autistic people—are openly available.

AI tool estimates social ability by analyzing speech
The system’s code and training data—drawn from one of the largest databases of speech recordings from autistic people—are openly available.